Saw Palmetto (Serenoa repens)

What Saw Palmetto Actually Is

Serenoa repens is a dwarf palm native to the south-eastern United States. The supplement is a liposterolic extract of its berries — a concentrate of fatty acids (lauric, oleic, myristic) and phytosterols (beta-sitosterol among them) standardised to roughly 85–95% of those fractions. That extract, at 320 mg/day, is what the clinical trials used. Dried berry powder in a capsule is a different product with a fraction of the active content, and its labelled milligrams do not translate.

The extract inhibits 5-alpha-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). That is the entire basis of its reputation in hair loss, and it is real as far as it goes. The problem is the comparison. Finasteride inhibits the type II isoform almost completely at 1 mg; saw palmetto inhibits both isoforms weakly and non-competitively. "Natural DHT blocker" is a marketing phrase that describes the mechanism without describing the magnitude.

The Evidence in Hair Loss

There is exactly one trial that answers the question people are actually asking — is it as good as the drug? — and it answered no.

The two-year head-to-head (2012). An open-label study enrolled 100 men with mild to moderate androgenetic alopecia and gave half saw palmetto 320 mg/day and half finasteride 1 mg/day for 24 months, scoring global photographs at baseline and at two years. 38% of the saw palmetto group showed an increase in hair growth against 68% of the finasteride group. Finasteride was more effective in two-thirds of the men with stage II and III loss (33 of 50). The investigators also noted that finasteride acted at both the frontal area and the vertex, while saw palmetto's effect was mostly confined to the vertex.

Read that carefully. Saw palmetto did something — 38% is not nothing — but the trial had no placebo arm, so how much of that 38% is regression to the mean, photography noise, or the natural variability of a slow disease cannot be separated. Finasteride's own placebo-controlled data put its two-year response well above the placebo rate; saw palmetto has no equivalent anchor.

The systematic review (2020). A review of the alopecia literature found five randomised trials and two prospective cohorts of oral or topical products containing saw palmetto at 100–320 mg, reporting a 27% improvement in total hair count in one, increased density in 83.3% of patients in another, and stabilised progression in 52% in a third. The authors' own conclusion is the honest one: robust high-quality data are lacking, most of the products were multi-ingredient blends, and trials isolating saw palmetto's sole contribution are still needed.

The placebo-controlled pilot (2002). The only double-blind placebo-controlled trial is a pilot in which 6 of 10 men on a saw palmetto and beta-sitosterol formulation were rated improved by blinded investigators. Ten men. It justified larger trials that, more than two decades later, have not been run.

What Saw Palmetto Has Never Shown

It has never beaten placebo in a properly powered hair-loss trial, because no such trial exists. Every positive number above comes from an open-label comparison, a multi-ingredient product, or a ten-man pilot.

It has never matched finasteride. The one direct comparison put it at roughly half the response rate.

And in the indication it is actually famous for — the prostate — the answer is worse. The 2012 Cochrane review pooled 32 randomised trials and 5,666 men and found saw palmetto no better than placebo on the American Urological Association symptom score (mean difference 0.25 points, 95% CI −0.58 to 1.07). In a 72-week high-quality trial, double and triple doses did no better: the proportion of responders was 42.6% on saw palmetto versus 44.2% on placebo. Peak urine flow, nocturia and prostate volume were all unchanged. The compound's flagship indication is essentially null at any dose tested, which is worth remembering when its 5-AR inhibition is presented as potent.

Dosing

The extract is lipophilic — take it with a meal containing fat. There is no evidence that exceeding 320 mg adds anything; the Cochrane prostate data tested double and triple doses and found no dose-response at all.

Time horizon: the head-to-head ran two years. A hair follicle's anagen phase is measured in years and the visible consequence of any intervention lags by months. Judging saw palmetto — or anything else in this space — before six months of standardised photographs is judging noise.

Safety

This is the one area where saw palmetto compares well with the drug. Finasteride's sexual adverse-effect signal in androgenetic alopecia is contested — one meta-analysis of 15 placebo-controlled trials put the relative risk of sexual dysfunction at 1.57, another found no significant increase — but the debate exists. Saw palmetto has no equivalent signal in the alopecia literature.

The interaction that matters is bleeding. A case report describes severe intraoperative haemorrhage in a patient taking the extract whose prolonged bleeding time normalised within days of stopping it, and it is not the only such report. Stop saw palmetto at least two weeks before surgery and do not combine it with anticoagulants or antiplatelet drugs without a prescriber knowing.

Avoid it in pregnancy: an anti-androgen, however weak, has no defensible role during gestation of a male foetus.

Who This Is Reasonable For

A man with early, slowly progressing pattern loss who has decided against finasteride — for side-effect concerns or simple preference — and who understands he is choosing a weaker tool. Used that way, at 320 mg of a standardised extract, it is safe, cheap and plausibly worth something at the vertex.

It is not reasonable as a substitute for finasteride in a man losing hair quickly, because the follicles miniaturised while a half-strength inhibitor was given its six-month trial do not come back. The full argument for where it sits, and what should come before it, is in The Hair Retention Protocol.

Related Research

• Hair Loss Science: DHT, Follicles and What Actually Works
• The Hair Retention Protocol
• Rosemary Oil vs Minoxidil: What the 2015 Trial Actually Showed
• Tongkat Ali